Sanofi (NYSE:SNY) to Build New Plant in Vietnam to Meet Higher Demand; $75 Million Plan – SNY, BMY, GSK, MRK

Sanofi SA (ADR) (NYSE:SNY) announced on Friday that it will invest $75 million in a new facility in Vietnam to meet higher demand in the country for pharmaceuticals and consumer healthcare products.

French pharmaceutical company announced on Friday that the plant is planned to start production from 2015 end and will be constructed in Ho Chi Minh City.

New facility will have an initial capacity of 90 million units per year, with a likely addition to 150 million units.

The drug giant announced its products have been present in Vietnam for over 50 years and the new facility will further support its leading position in emerging markets comprising Southeast Asia.

Shifting reader’s focus to broader market, let us consider market performance of other stocks that significantly affect same sector. Bristol Myers Squibb Co. (NYSE:BMY) rose +1.01% to settle at $41.19, GlaxoSmithKline plc (ADR) (NYSE:GSK) moved up +1.14% to end at $46.91 while Merck & Co., Inc. (NYSE:MRK) jumped +0.23% to finish at $44.20 on Friday.

Sanofi SA (ADR) (NYSE:SNY) last session’s volume of 3.02 million shares was surprisingly higher than its average volume of 2.67 million shares. The stock after opening at $50.52 hit high price of $51.29 and then closed at $51.08 by scoring +1.85%.

The liquidity measure in recent quarter results of the company was recorded 1.65 as current ratio and on the other side the debt to equity ratio was 0.25 and long-term debt to equity ratio remained at 0.19. The Company had total cash of $8.39 billion at hand and a book value per share as $28.05 in the most recent quarter.

The stock’s price volatility was 1.54% for a week and 1.40% for a month as well as price volatility’s Average True Range for 14 days was 1.02 and its beta remained at 0.91.

SNY generated revenue of $46.09 billion in the previous twelve months and earned $6.37 billion. The Company showed a positive 13.19% in the net profit margin as well as in its operating margin which remained at 17.62%. Company’s annual sales growth for the past five years was 4.25%.

DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with! CLICK HERE TO START YOUR FREE 30-DAY TRIAL

This entry was posted in Healthcare, Latest Headlines and tagged , , , , , , , , , , , . Bookmark the permalink.